Shares of Bath & Body Works, Inc. (NYSE:BBWI - Get Free Report) gapped down before the market opened on Thursday . The stock had previously closed at $41.08, but opened at $36.65. Bath & Body Works shares last traded at $36.60, with a volume of 1,617,941 shares traded.
Wall Street Analyst Weigh In
Several analysts have recently commented on BBWI shares. Barclays reduced their price objective on shares of Bath & Body Works from $43.00 to $38.00 and set an "equal weight" rating for the company in a research report on Monday. Wells Fargo & Company raised shares of Bath & Body Works from an "equal weight" rating to an "overweight" rating and lifted their price target for the company from $42.00 to $48.00 in a research report on Friday, January 10th. Robert W. Baird lifted their price target on shares of Bath & Body Works from $45.00 to $47.00 and gave the company an "outperform" rating in a research report on Friday. Piper Sandler lifted their price target on shares of Bath & Body Works from $36.00 to $39.00 and gave the company a "neutral" rating in a research report on Monday, January 6th. Finally, TD Cowen lifted their price target on shares of Bath & Body Works from $42.00 to $48.00 and gave the company a "buy" rating in a research report on Thursday, December 12th. Five equities research analysts have rated the stock with a hold rating and thirteen have given a buy rating to the stock. According to data from MarketBeat.com, the stock has an average rating of "Moderate Buy" and a consensus target price of $45.06.
View Our Latest Stock Analysis on BBWI
Bath & Body Works Stock Performance
The company has a market capitalization of $7.66 billion, a P/E ratio of 8.63, a PEG ratio of 0.92 and a beta of 1.83. The stock has a 50 day moving average price of $37.63 and a 200 day moving average price of $34.17.
Bath & Body Works (NYSE:BBWI - Get Free Report) last announced its quarterly earnings data on Thursday, February 27th. The company reported $2.09 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $2.04 by $0.05. Bath & Body Works had a negative return on equity of 44.03% and a net margin of 12.43%. The business had revenue of $2.79 billion for the quarter, compared to analysts' expectations of $2.78 billion. As a group, sell-side analysts expect that Bath & Body Works, Inc. will post 3.3 earnings per share for the current year.
Bath & Body Works Dividend Announcement
The company also recently disclosed a quarterly dividend, which will be paid on Friday, March 7th. Investors of record on Friday, February 21st will be paid a $0.20 dividend. This represents a $0.80 dividend on an annualized basis and a yield of 2.26%. The ex-dividend date is Friday, February 21st. Bath & Body Works's dividend payout ratio is currently 21.98%.
Bath & Body Works declared that its board has authorized a share buyback plan on Thursday, February 27th that authorizes the company to buyback $500.00 million in shares. This buyback authorization authorizes the company to buy up to 6.4% of its shares through open market purchases. Shares buyback plans are often a sign that the company's leadership believes its shares are undervalued.
Institutional Inflows and Outflows
A number of hedge funds have recently added to or reduced their stakes in the stock. Shufro Rose & Co. LLC purchased a new position in Bath & Body Works during the 4th quarter valued at about $343,000. American Trust purchased a new position in Bath & Body Works during the 4th quarter valued at about $205,000. Public Employees Retirement System of Ohio purchased a new position in Bath & Body Works during the 4th quarter valued at about $2,920,000. Alpine Global Management LLC purchased a new position in Bath & Body Works during the 4th quarter valued at about $576,000. Finally, Northwest Bank & Trust Co grew its holdings in shares of Bath & Body Works by 2.9% during the fourth quarter. Northwest Bank & Trust Co now owns 14,700 shares of the company's stock worth $533,000 after purchasing an additional 419 shares in the last quarter. Hedge funds and other institutional investors own 95.14% of the company's stock.
Bath & Body Works Company Profile
(
Get Free Report)
Bath & Body Works, Inc is a specialty retailers and home to America's Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.
Read More
Before you consider Bath & Body Works, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Bath & Body Works wasn't on the list.
While Bath & Body Works currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are likely to thrive in today's challenging market? Enter your email address and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.